| James H Mcclenathan, MD | |
|
2800 E Ajo Way, Tucson, AZ 85713-6204 | |
| (520) 874-2000 | |
| Not Available |
| Full Name | James H Mcclenathan |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 52 Years |
| Location | 2800 E Ajo Way, Tucson, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053498907 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | G31416 (California) | Secondary |
| 208600000X | Surgery | 37334 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Banner-university Medical Center South Campus | Tucson, AZ | Hospital |
| Banner - University Medical Center Tucson Campus | Tucson, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Banner -- University Medical Group | 7719899871 | 819 |
News Archive
Despite decades-long prevention and treatment efforts, cardiovascular (CV) disease continues to be the leading cause of death worldwide.
The most commonly used gene expression profile test used to help predict breast cancer recurrence may not be as cost-effective as once thought, say a team of researchers led by Georgetown Lombardi Comprehensive Cancer Center.
Researchers at the David Geffen School of Medicine at UCLA have solved the structure of a class of proteins known as sodium glucose co-transporters (SGLTs), which pump glucose into cells.
Artemisinin, a potent anti-malarial drug, has been widely hailed as a promising alternative cancer treatment. Scientists from the National University of Singapore recently showed that its anti-cancer properties could be enhanced by 10 folds when used in combination with Aminolaevulinic acid, a photosensitizer or a drug which, upon exposure to light, leads to generation of free radicals that can kill cells.
› Verified 7 days ago
| Entity Name | Banner -- University Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508809427 PECOS PAC ID: 7719899871 Enrollment ID: O20031105000694 |
News Archive
Despite decades-long prevention and treatment efforts, cardiovascular (CV) disease continues to be the leading cause of death worldwide.
The most commonly used gene expression profile test used to help predict breast cancer recurrence may not be as cost-effective as once thought, say a team of researchers led by Georgetown Lombardi Comprehensive Cancer Center.
Researchers at the David Geffen School of Medicine at UCLA have solved the structure of a class of proteins known as sodium glucose co-transporters (SGLTs), which pump glucose into cells.
Artemisinin, a potent anti-malarial drug, has been widely hailed as a promising alternative cancer treatment. Scientists from the National University of Singapore recently showed that its anti-cancer properties could be enhanced by 10 folds when used in combination with Aminolaevulinic acid, a photosensitizer or a drug which, upon exposure to light, leads to generation of free radicals that can kill cells.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James H Mcclenathan, MD 2800 E Ajo Way, Tucson, AZ 85713-6204 Ph: (520) 874-2000 | James H Mcclenathan, MD 2800 E Ajo Way, Tucson, AZ 85713-6204 Ph: (520) 874-2000 |
News Archive
Despite decades-long prevention and treatment efforts, cardiovascular (CV) disease continues to be the leading cause of death worldwide.
The most commonly used gene expression profile test used to help predict breast cancer recurrence may not be as cost-effective as once thought, say a team of researchers led by Georgetown Lombardi Comprehensive Cancer Center.
Researchers at the David Geffen School of Medicine at UCLA have solved the structure of a class of proteins known as sodium glucose co-transporters (SGLTs), which pump glucose into cells.
Artemisinin, a potent anti-malarial drug, has been widely hailed as a promising alternative cancer treatment. Scientists from the National University of Singapore recently showed that its anti-cancer properties could be enhanced by 10 folds when used in combination with Aminolaevulinic acid, a photosensitizer or a drug which, upon exposure to light, leads to generation of free radicals that can kill cells.
› Verified 7 days ago
Dr. Timothy M Rankin, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1501 N Campbell Ave, Dept Of Surgery, Tucson, AZ 85724 Phone: 714-457-1786 | |
Bashir Adam Koko, MBBS Surgery Medicare: Medicare Enrolled Practice Location: 1501 N Campbell Ave Rm 5304, Tucson, AZ 85724 Phone: 520-626-7747 Fax: 520-626-2247 | |
Dr. Patrick A Smith, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1951 N Wilmot Rd, Building 2, Tucson, AZ 85712 Phone: 520-795-5845 Fax: 520-795-8620 | |
Dr. Michele Lynn Boyce Ley, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2625 N Craycroft Rd Ste 201, Tucson, AZ 85712 Phone: 520-827-4502 Fax: 520-323-0076 | |
Dr. Silvia Kurtovic, MD Surgery Medicare: Medicare Enrolled Practice Location: 5780 N Swan Rd Ste 180, Tucson, AZ 85718 Phone: 520-448-9490 Fax: 520-448-9492 | |
Bo Zhang, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 1501 N Campbell Ave, Rm 4334, Tucson, AZ 85724 Phone: 520-626-7747 Fax: 520-626-2247 | |
James C Balserak, MD Surgery Medicare: Medicare Enrolled Practice Location: 5301 E Grant Rd, Tucson, AZ 85712 Phone: 520-324-5461 Fax: 520-795-8620 |